Why weight-loss drugs might be reducing cancer rates and making treatment more effective Ariana Eunjung Cha, Christopher Rowland | Washington Post | June 10, 2026

https://geneticliteracyproject.org/2026/06/10/why-weight-loss-drugs-might-be-reducing-cancer-rates-and-making-treatment-more-effective/ At this year’s American Society of Clinical Oncology (ASCO) meeting in Chicago, more than 40 studies, abstracts, oral presentations and poster presentations examined the relationship between GLP-1-based drugs and cancer. The results were strikingly consistent. Taken together, they suggest that people taking medications such as Ozempic, Wegovy and Mounjaro may develop certain cancers at lower rates than comparable patients who are not taking the drugs — and that those already diagnosed may experience a slower decline and better outcomes.